JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$4.65B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$2.08B |
| 3 |
Microsoft
MSFT
|
+$2.05B |
| 4 |
Vanguard Total International Bond ETF
BNDX
|
+$1.64B |
| 5 |
Micron Technology
MU
|
+$1.39B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AMJ
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
|
+$2.4B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.11B |
| 3 |
Progressive
PGR
|
+$1.64B |
| 4 |
Salesforce
CRM
|
+$1.54B |
| 5 |
Adobe
ADBE
|
+$1.41B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.15% |
| 2 | Technology | 24.03% |
| 3 | Healthcare | 9.24% |
| 4 | Consumer Discretionary | 8.79% |
| 5 | Financials | 8.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4526
CALL
West Pharmaceutical
WST
$25.7B
| $461K | ﹤0.01% |
1,400
-5,000
| -78% | -$1.77M |
2023 Q3
3 quarters
|
|
4527
Navitas Semiconductor
NVTS
$3.26B
| $461K | ﹤0.01% |
117,297
+29,477
| +34% | +$124K |
2022 Q2
8 quarters
|
|
4528
Omega Flex
OFLX
$266M
| $458K | ﹤0.01% |
8,934
-466
| -5% | -$29.7K |
2017 Q4
26 quarters
|
|
4529
PUT
Casey's General Stores
CASY
$22.8B
| $458K | ﹤0.01% |
+1,200
| New | +$400K |
2024 Q2
0 quarters
|
|
4530
CALL
Burlington
BURL
$17.3B
| $456K | ﹤0.01% |
1,900
-78,100
| -98% | -$16.1M |
2024 Q1
1 quarter
|
|
4531
Richardson Electronics
RELL
$282M
| $452K | ﹤0.01% |
38,017
+32,979
| +655% | +$351K |
2023 Q1
5 quarters
|
|
4532
iShares Russell 2500 ETF
SMMD
$4.08B
| $451K | ﹤0.01% |
7,208
-3,644
| -34% | -$229K |
2022 Q4
6 quarters
|
|
4533
State Street SPDR S&P International Dividend ETF
DWX
$509M
| $451K | ﹤0.01% |
13,098
-704
| -5% | -$24.5K |
2017 Q1
29 quarters
|
|
|
ETNB
4534
DELISTED
89bio
ETNB
| $449K | ﹤0.01% |
56,083
-4,730
| -8% | -$42.2K |
2019 Q4
18 quarters
|
|
4535
FT Vest US Equity Buffer ETF April
FAPR
$1.33B
| $447K | ﹤0.01% |
+11,457
| New | +$432K |
2024 Q2
0 quarters
|
|
|
TELL
4536
DELISTED
Tellurian Inc.
TELL
| $447K | ﹤0.01% |
645,429
+400,978
| +164% | +$222K |
2017 Q4
26 quarters
|
|
4537
Park-Ohio Holdings
PKOH
$686M
| $445K | ﹤0.01% |
17,185
-9,049
| -34% | -$230K |
2013 Q2
44 quarters
|
|
4538
Bioventus
BVS
$897M
| $444K | ﹤0.01% |
77,298
-29,208
| -27% | -$160K |
2021 Q1
13 quarters
|
|
4539
Peoples Bancorp
PEBO
$1.35B
| $444K | ﹤0.01% |
14,800
-47,958
| -76% | -$1.39M |
2016 Q4
30 quarters
|
|
4540
Fidelity MSCI Communication Services Index ETF
FCOM
$1.83B
| $444K | ﹤0.01% |
8,500
-15,617
| -65% | -$784K |
2022 Q1
9 quarters
|
|
4541
iShares MSCI Qatar ETF
QAT
$56.2M
| $444K | ﹤0.01% |
26,294
-4,227
| -14% | -$72.2K |
2022 Q1
9 quarters
|
|
4542
Tango Therapeutics
TNGX
$3.92B
| $442K | ﹤0.01% |
51,559
-71,138
| -58% | -$550K |
2021 Q3
11 quarters
|
|
|
XHYE
4543
DELISTED
BondBloxx USD High Yield Bond Energy Sector ETF
XHYE
| $442K | ﹤0.01% |
+11,284
| New | +$440K |
2024 Q2
0 quarters
|
|
4544
FT Vest US Equity Buffer ETF June
FJUN
$1.43B
| $442K | ﹤0.01% |
9,134
-7,425
| -45% | -$352K |
2022 Q4
6 quarters
|
|
4545
CALL
RH
RH
$2.28B
| $440K | ﹤0.01% |
+1,800
| New | +$473K |
2024 Q2
0 quarters
|
|
|
VISN
4546
Vistance Networks Inc
VISN
$1.43B
| $439K | ﹤0.01% |
357,295
-479,240
| -57% | -$570K |
2013 Q4
42 quarters
|
|
4547
W&T Offshore
WTI
$537M
| $439K | ﹤0.01% |
205,241
-179,034
| -47% | -$416K |
2016 Q4
30 quarters
|
|
4548
CALL
Acadia Pharmaceuticals
ACAD
$3.44B
| $439K | ﹤0.01% |
27,000
+19,300
| +251% | +$311K |
2024 Q1
1 quarter
|
|
|
4549
PUT
Acadia Pharmaceuticals
ACAD
$3.44B
| $439K | ﹤0.01% |
27,000
-73,000
| -73% | -$1.18M |
2024 Q1
1 quarter
|
|
|
ADAM
4550
Adamas Trust
ADAM
$702M
| $439K | ﹤0.01% |
75,090
-229,292
| -75% | -$1.47M |
2015 Q3
35 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2024 Portfolio in Review
As of Q2 2024, JP Morgan Chase held 7,917 positions worth $1.22T, up 3% from $1.18T the previous quarter. Its ten largest holdings account for 24% of the portfolio.
JP Morgan Chase's Q2 2024 filing shows 549 new, 2,506 increased, 3,286 reduced and 578 closed positions. Its largest new stake was BlackRock Flexible Income ETF: 6,829,171 shares worth $357M. The largest sale was JP Morgan Alerian MLP Index ETN 5/24/24, an estimated $2.4B.
By sector, the portfolio is most concentrated in Miscellaneous at 24% of assets, down from 25% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q2 2024 buy was BlackRock Flexible Income ETF: 6,829,171 shares worth $357M.
- JP Morgan Chase added most to Apple in Q2 2024, an estimated $4.65B increase.
- JP Morgan Chase's biggest Q2 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.11B.
- JP Morgan Chase fully exited JP Morgan Alerian MLP Index ETN 5/24/24 in Q2 2024, selling an estimated $2.4B.
- JP Morgan Chase's ten largest holdings make up 24% of its $1.22T portfolio in Q2 2024.
- JP Morgan Chase opened 549 new positions and closed 578 in Q2 2024.
- JP Morgan Chase's portfolio value rose 3% quarter-over-quarter to $1.22T.
Based on JP Morgan Chase's 13F filing for Q2 2024, filed 12 Aug 2024.